|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| C07K 14/47 | |||
| A61K 48/00 | |||
| C07K 16/40 | |||
| C12N 15/00 | |||
| A61P 25/28 | |||
| A61P 3/10 | |||
| A61P 41/00 | |||
| A61P 13/12 | |||
| A61K 38/55 | |||
| A61P 1/00 | |||
| A61P 1/02 | |||
| A61P 1/04 | |||
| A61P 1/16 | |||
| A61P 1/18 | |||
| A61P 3/00 | |||
| A61P 3/08 | |||
| A61P 5/00 |
| (11) | Number of the document | 3013353 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14734003.8 |
| Date of filing the European patent application | 2014-06-26 | |
| (97) | Date of publication of the European application | 2016-05-04 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/001736 |
| Date | 2014-06-26 |
| (87) | Number | WO 2014/206563 |
| Date | 2014-12-31 |
| (30) | Number | Date | Country code |
| PCT/EP2013/0018 | 2013-06-26 | WO | |
| PCT/EP2013/0018 | 2013-06-27 | WO |
| (72) |
COMBETTE, Jean-Marc, FR
DELOCHE, Catherine, CH
|
| (73) |
Xigen Inflammation Ltd.,
Arch. Makariou III 195 Neocleous House, 3030 Limassol,
CY
|
| (54) | CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS |
| CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS |